Oncology Institute, Inc. (TOIIW) — DEF 14A Filings
All DEF 14A filings from Oncology Institute, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Oncology Institute Files Proxy Statement for May Meeting
— Mar 27, 2025 Risk: low
The Oncology Institute, Inc. filed a definitive proxy statement (DEF 14A) on March 27, 2025, for its annual meeting on May 7, 2025. The company, formerly known -
Oncology Institute, Inc. Announces Annual Meeting of Stockholders on June 13, 2024
— May 2, 2024 Risk: low
Oncology Institute, Inc. (TOIIW) filed a Proxy Statement (DEF 14A) with the SEC on May 2, 2024. The Oncology Institute, Inc. will hold its annual meeting of sto
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX